Abstract
Per the Editor’s recommendation, we are resubmitting this revised article as a “Clinical
Challenges in Urology” article. Based on the Gold Journal guidelines, no abstract
is required for this article type.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to UrologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.J Urol. 1992; 147: 596-600https://doi.org/10.1016/S0022-5347(17)37316-0
- Cystoprostatectomy and orthotopic ileal neobladder reconstruction for management of bacille Calmette Guérin-induced bladder contractures.Urology. 2005; 65: 909-912https://doi.org/10.1016/J.UROLOGY.2004.11.053
- Combination drug therapy improves compliance of the neurogenic bladder.J Urol. 2009; 182: 1062-1067https://doi.org/10.1016/J.JURO.2009.05.038
- The use of mirabegron in neurogenic bladder: a systematic review.World J Urol. 2020; 38: 2435-2442https://doi.org/10.1007/S00345-019-03040-X
- Does the type of bladder augmentation influence the resolution of pre-existing vesicoureteral reflux? Urodynamic studies.Neurourol Urodyn. 2008; 27: 412-416https://doi.org/10.1002/NAU.20529
- Augmentation cystoplasty: Urodynamic and metabolic outcomes at 10-year follow-up.Int J Urol. 2015; 22: 1149-1154https://doi.org/10.1111/IJU.12943
Article info
Publication history
Accepted:
May 16,
2023
Received in revised form:
May 15,
2023
Received:
January 18,
2023
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2023 Elsevier Inc. All rights reserved.
